Benchmark Capital downgrades BioMarin (Nasdaq: BMRN) from Buy to Hold.

Benchmark analyst says, "We are downgrading BioMarin to Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE